Reproducibility of in-hospital worsening heart failure event adjudication in the RELAX-AHF-EU trial
- PMID: 31359535
- DOI: 10.1002/ejhf.1574
Reproducibility of in-hospital worsening heart failure event adjudication in the RELAX-AHF-EU trial
References
-
- Packer M, O'Connor C, McMurray JJ, Wittes J, Abraham WT, Anker SD, Dickstein K, Filippatos G, Holcomb R, Krum H, Maggioni AP, Mebazaa A, Peacock WF, Petrie MC, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Kowarski LS, Schactman M, Holzmeister J; TRUE-AHF Investigators. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med 2017;376:1956-1964.
-
- Sato N, Lam CSP, Teerlink JR, Greenberg BH, Tsutsui H, Oh BH, Zhang J, Lefkowitz M, Hua TA, Holbro T, Marshood M, Wang XL, Ge J. Evaluating the efficacy, safety, and tolerability of serelaxin when added to standard therapy in Asian patients with acute heart failure: design and rationale of RELAX-AHF-ASIA Trial. J Card Fail 2017;23:63-71.
-
- Maggioni AP, López-Sendón J, Nielsen OW, Hallén J, Aalamian-Mattheis M, Wang Y, Ertl G. Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU. Eur J Heart Fail 2019;21:322-333.
-
- Davison BA, Metra M, Cotter G, Massie BM, Cleland JG, Dittrich HC, Edwards C, Filippatos G, Givertz MM, Greenberg B, Ponikowski P, Voors AA, O'Connor CM, Teerlink JR; PROTECT and RELAX-AHF Executive Committees. Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC Heart Fail 2015;3:395-403.
-
- Carubelli V, Cotter G, Davison B, Gishe J, Senger S, Bonadei I, Gorga E, Lazzarini V, Lombardi C, Metra M. In-hospital worsening heart failure in patients admitted for acute heart failure. Int J Cardiol 2016;225:353-361.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical